Gábor Reuter1, Péter Pankovics, György Szucs. 1. Regional Laboratory of Virology, ANTSZ Regional Institute of State Public Health Service, Szabadság út 7, H-7623 Pécs, Hungary. reuter.gabor@baranya.antsz.hu
Abstract
BACKGROUND: Noroviruses are common pathogens in human gastroenteritis outbreaks worldwide. They belong to a genetically diverse group of RNA viruses with multiple genogroups (G) and genotypes. Genotype GII-4 norovirus (Lordsdale) is the predominant agent in epidemics. OBJECTIVES: To investigate the genetic variation in GII-4 strains isolated during seven epidemic seasons in Hungary from November 2000 to June 2007. STUDY DESIGN: Using the prospective epidemiological surveillance of norovirus outbreaks in Hungary, GII-4 strains were selected for further genetic analysis. After phylogenetic analysis, RNA-polymerase (open reading frame 1; ORF1), capsid (ORF2) and the ORF1/ORF2 junction were analysed by RT-PCR and sequencing. RESULTS: Three hundred and seventy-seven (76.8%) of 491 confirmed norovirus outbreaks were caused by genotype GII-4. GII-4 was the predominant genotype in six of the seven epidemic seasons. Four main GII-4 variants--epidemic point mutants--(GII-4-2000, GII-4-2002, GII-4-2004 and GII-4-2006b) were detected, with each variant predominating in two consecutive epidemic seasons. CONCLUSIONS: Genotype GII-4 was confirmed as the predominant genetic type in epidemic norovirus seasons in Hungary. Genetic drift successfully promotes the re-emergence of GII-4 variants in the population. The elevated number of norovirus outbreaks in the population predicts the emergence of new GII-4 genetic variants as part of an international epidemic.
BACKGROUND: Noroviruses are common pathogens in humangastroenteritis outbreaks worldwide. They belong to a genetically diverse group of RNA viruses with multiple genogroups (G) and genotypes. Genotype GII-4 norovirus (Lordsdale) is the predominant agent in epidemics. OBJECTIVES: To investigate the genetic variation in GII-4 strains isolated during seven epidemic seasons in Hungary from November 2000 to June 2007. STUDY DESIGN: Using the prospective epidemiological surveillance of norovirus outbreaks in Hungary, GII-4 strains were selected for further genetic analysis. After phylogenetic analysis, RNA-polymerase (open reading frame 1; ORF1), capsid (ORF2) and the ORF1/ORF2 junction were analysed by RT-PCR and sequencing. RESULTS: Three hundred and seventy-seven (76.8%) of 491 confirmed norovirus outbreaks were caused by genotype GII-4. GII-4 was the predominant genotype in six of the seven epidemic seasons. Four main GII-4 variants--epidemic point mutants--(GII-4-2000, GII-4-2002, GII-4-2004 and GII-4-2006b) were detected, with each variant predominating in two consecutive epidemic seasons. CONCLUSIONS: Genotype GII-4 was confirmed as the predominant genetic type in epidemic norovirus seasons in Hungary. Genetic drift successfully promotes the re-emergence of GII-4 variants in the population. The elevated number of norovirus outbreaks in the population predicts the emergence of new GII-4 genetic variants as part of an international epidemic.
Authors: Tommy Tsan-Yuk Lam; Huachen Zhu; David K Smith; Yi Guan; Edward C Holmes; Oliver G Pybus Journal: J Gen Virol Date: 2012-01-13 Impact factor: 3.891
Authors: Lisa C Lindesmith; Eric Donaldson; Juan Leon; Christine L Moe; Jeffrey A Frelinger; Robert E Johnston; David J Weber; Ralph S Baric Journal: J Virol Date: 2009-12-09 Impact factor: 5.103
Authors: Karin Bok; Eugenio J Abente; Mauricio Realpe-Quintero; Tanaji Mitra; Stanislav V Sosnovtsev; Albert Z Kapikian; Kim Y Green Journal: J Virol Date: 2009-09-16 Impact factor: 5.103
Authors: X Zhou; H Li; L Sun; Y Mo; S Chen; X Wu; J Liang; H Zheng; C Ke; J K Varma; J D Klena; Q Chen; L Zou; X Yang Journal: Epidemiol Infect Date: 2012-03-08 Impact factor: 4.434
Authors: Helena Skar; Ryan N Gutenkunst; Karin Wilbe Ramsay; Annette Alaeus; Jan Albert; Thomas Leitner Journal: PLoS One Date: 2011-08-02 Impact factor: 3.240
Authors: M C Medici; F Tummolo; V Martella; C Chezzi; M C Arcangeletti; F De Conto; A Calderaro Journal: Epidemiol Infect Date: 2014-01-20 Impact factor: 4.434
Authors: Claudia P Campillay-Véliz; Jonatan J Carvajal; Andrea M Avellaneda; Darling Escobar; Camila Covián; Alexis M Kalergis; Margarita K Lay Journal: Front Immunol Date: 2020-06-16 Impact factor: 7.561